UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025915
Receipt number R000029796
Scientific Title A single-center, prospective pilot study to elucidate the fluorescence diagnostic ability of 5-aminolevulinic acid for cholangiocarcinoma
Date of disclosure of the study information 2017/04/01
Last modified on 2019/09/24 18:48:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A single-center, prospective pilot study to elucidate the fluorescence diagnostic ability of 5-aminolevulinic acid for cholangiocarcinoma

Acronym

A novel fluorescence diagnostic method of cholangiocarcinoma using 5-aminolevulinic acid

Scientific Title

A single-center, prospective pilot study to elucidate the fluorescence diagnostic ability of 5-aminolevulinic acid for cholangiocarcinoma

Scientific Title:Acronym

A novel fluorescence diagnostic method of cholangiocarcinoma using 5-aminolevulinic acid

Region

Japan


Condition

Condition

cholangiocarcinoma

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the diagnostic ability of evalating 5-ALA expression under direct cholangioscopy in cholangiocarcinoma.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Accuracy rate of diagnosis of cholangiocarcinoma by evalation of expression of protoporphyrinIX

Key secondary outcomes

1.Technical success rate
2.Comparison between normal light, NBI observation and fluorescence observation for evalation of mucosal cancerous extension
3.Rate of complication
4.Rate of drug-related adverse event


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

Period of implementation: 3 days
Maximum observation period: 12 months
A single dose of 5-ALA (5-ALA 20 mg / kg dissolved in 200 ml of water; dosage approved as an intraoperative diagnostic for brain tumor)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Bile duct stenosis suspected of cholangiocarcinoma
2. Patients who obtained informed concent
3. 20 years of age or older

Key exclusion criteria

1. Cases in ECOG performance status 4
2. Cases with serious complications in other organs
3. Cases who have difficulty in endoscopic approach via the ampulla of Vater
4. Cases under 20 years of age
5. Cases who don't give informed consent 6. Cases with hypersensitivity porphyrin related substances or its previous history
7. Cases with porphyria
8. Pregnant women or cases who may be pregnant
9. Other cases that the research responsibility (share) person judged inappropriate as the research subject

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hironari
Middle name
Last name Kato

Organization

Okayama University Hospital

Division name

Departments of Gastroenterology

Zip code

700-8558

Address

2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.

TEL

086-235-7219

Email

drkatocha@yahoo.co.jp


Public contact

Name of contact person

1st name Shinichiro
Middle name
Last name Muro

Organization

Okayama University Hospital

Division name

Depertment of Endoscopy

Zip code

700-8558

Address

2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan

TEL

086-235-7219

Homepage URL


Email

shinm0416@yahoo.co.jp


Sponsor or person

Institute

Okayama University Hospital

Institute

Department

Personal name



Funding Source

Organization

SBI Pharmaceuticals Co.

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama University Hospital

Address

2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan

Tel

086-235-7218

Email

shinm0416@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岡山大学病院(岡山県)


Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 03 Month 29 Day

Date of IRB

2017 Year 03 Month 21 Day

Anticipated trial start date

2017 Year 05 Month 01 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 01 Month 31 Day

Last modified on

2019 Year 09 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029796


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name